ReviewFrontiers in public health2025
Flora and fauna: how nonhuman species interact with natural and man-made EMF at ecosystem levels and public policy recommendations.
Review in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- U.S. policy on wireless technologies and public health protection: regulatory gaps and proposed reforms.Frontiers in public health · 2025Review
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the last 60 years, there has been a steady increase in ambient exposures from nonionizing electromagnetic fields (EMF) between 0 and 300 GHz, primarily in the radiofrequency (RF) ranges between 30 kHz and 3 GHz. Each technology has introduced a layer of exposures with different transmission characteristics into the environment, creating what is today a broad scope of complex chronic, low-intensity, ambient exposures known to be biologically active in human and nonhuman species alike. The next generation of broadband technology employs a wide span of simultaneous frequency exposures for pervasive civilian use with signaling characteristics heretofore never deployed. Fifth and sixth generation (5G, 6G) networks utilize significantly higher areas of the electromagnetic spectrum >3.5 GHz unlike previous wireless technologies. The scale at which this EMF deployment unfolded has now reached documented proportions that simply do not exist in nature, creating 24/7 exposures to a novel energetic form of air pollution. While there are extensive local variations in exposure intensities, e.g., rural versus urban environments with proximity to transmission sources being the controlling variable, the advent of significantly increased satellites in low earth orbits, disseminating radiofrequency EMF (RF-EMF) toward Earth in broad radiation patterns, has now all but erased such demographic distinctions. Nowhere on Earth today is completely RF-EMF free. Nonhuman species are highly sensitive to the Earth's geomagnetic fields which are used for orientation, migration, mating, food finding, territorial defense, and all of life's activities. Compared to human abilities, myriad species have evolved an exceptionally sensitive physical array of electro/magneto-receptors with which to perceive environmental EMF often at, or very near, natural geomagnetic fields. Today's exposures are capable, even at very low intensities, of disrupting critical fauna/flora functions. Any existing exposure standards are strictly for humans. Discussed are nonhuman unique physiologies and potential resonant matches at ambient levels today. Policy recommendations for wildlife protection includes discussion of "airspace as habitat," adherence to existing laws, and mitigation that could include frequency re-allocation, redesign of hardware and network engineering, and societies moving away from certain competitive economic models, as well as EMF-free zones during migration and breeding seasons where possible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.